Literature DB >> 7894215

Evidence for cardiovascular remodeling in a patient with Bartter's syndrome.

U Schmitz1, Y Ko, H Becher, M Ludwig, H Vetter, R Düsing.   

Abstract

In a 56-year-old normotensive white male subject with a 12-year history of hypokalemic alkalosis, hyperreninemia, and aldosteronism, the diagnosis of Bartter's syndrome was established on the basis of an impaired maximal renal diluting capacity and decreased distal fractional chloride absorption [CH2O/(CH2O+CCl)]. Negative urine analysis for diuretics suggested that this renal tubular defect was not secondary to diuretic (ab)use. In this normotensive patient with hyperreninemia and secondary aldosteronism, significant cardiovascular remodeling could be observed. Thus, in spite of normal arterial blood pressure and normal left ventricular systolic function (ejection fraction > 70%), impaired left ventricular diastolic function was observed using pulsed-wave Doppler echocardiography. Moreover, duplex analysis of the common carotid artery revealed significant intima-media hypertrophy with an average intima-media diameter of 0.9 mm (normal < or = 0.6 mm). Also, forearm venous occlusion plethysmography revealed an abnormally high minimal forearm vascular resistance following a 10-min period of forearm ischemia handgrip exercise suggesting remodeling within the peripheral arterioles. Thus, in a patient with Bartter's syndrome and activated neurohormonal systems such as the renin-angiotensin system, cardiac and vascular remodeling can be observed in the absence of hypertension. In analogy to the results of experimental studies showing that angiotensin II and noradrenaline act as growth factors on cardiac and vascular cells, cardiovascular remodeling present in our patient with Bartter's syndrome may be explained by increased activity of angiotensin II and/or noradrenaline.

Entities:  

Mesh:

Year:  1994        PMID: 7894215     DOI: 10.1007/bf00190744

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  25 in total

1.  Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome.

Authors:  F C BARTTER; P PRONOVE; J R GILL; R C MACCARDLE
Journal:  Am J Med       Date:  1962-12       Impact factor: 4.965

2.  The fourth Volhard lecture: cardiovascular structural adaptation; its role in the initiation and maintenance of primary hypertension.

Authors:  B Folkow
Journal:  Clin Sci Mol Med Suppl       Date:  1978-12

3.  Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction.

Authors:  M A Pfeffer; G A Lamas; D E Vaughan; A F Parisi; E Braunwald
Journal:  N Engl J Med       Date:  1988-07-14       Impact factor: 91.245

4.  Evidence for a prostaglandin-independent defect in chloride reabsorption in the loop of Henle as a proximal cause of Bartter's syncrome.

Authors:  J R Gill; F C Bartter
Journal:  Am J Med       Date:  1978-11       Impact factor: 4.965

5.  Hyperplasia of the juxtaglomerular complex with secondary aldosteronism without hypertension (Bartter's syndrome).

Authors:  N C Brackett; M Koppel; R E Randall; W P Nixon
Journal:  Am J Med       Date:  1968-05       Impact factor: 4.965

6.  Divergent responses of common carotid artery intimal-medial thickness to high blood pressure and hypercholesterolaemia in relation to age.

Authors:  M M Ludwig; U Jörger; S Lund; K O Stumpe
Journal:  J Hypertens Suppl       Date:  1993-12

Review 7.  Bartter's syndrome.

Authors:  J R Gill
Journal:  Annu Rev Med       Date:  1980       Impact factor: 13.739

8.  Correction of increased sympathoadrenal activity in Bartter's syndrome by inhibition of prostaglandin synthesis.

Authors:  H G Güllner; J R Gill; F C Bartter; C R Lake; D J Lakatua
Journal:  J Clin Endocrinol Metab       Date:  1980-05       Impact factor: 5.958

9.  Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response.

Authors:  P Simpson
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

10.  Growth-stimulating effect of catecholamines on rat aortic smooth muscle cells in culture.

Authors:  N Blaes; J P Boissel
Journal:  J Cell Physiol       Date:  1983-08       Impact factor: 6.384

View more
  2 in total

1.  Loss-of-function DNA sequence variant in the CLCNKA chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation.

Authors:  Thomas P Cappola; Scot J Matkovich; Wei Wang; Derek van Booven; Mingyao Li; Xuexia Wang; Liming Qu; Nancy K Sweitzer; James C Fang; Muredach P Reilly; Hakon Hakonarson; Jeanne M Nerbonne; Gerald W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-19       Impact factor: 11.205

2.  Perspective of future drugs targeting sterile 20/SPS1-related proline/alanine-rich kinase for blood pressure control.

Authors:  Gen-Min Lin; Pang-Yen Liu; Ching-Fen Wu; Wen-Been Wang; Chih-Lu Han
Journal:  World J Cardiol       Date:  2015-06-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.